B12 and Twynsta drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take B12 (cobalamin) and Twynsta (amlodipine besylate; telmisartan). Common drug interactions include nasopharyngitis among females and crohn's disease among males.
The phase IV clinical study analyzes what interactions people have when they take B12 and Twynsta. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.
What is B12?
B12 has active ingredients of cobalamin. It is often used in vitamin b12 deficiency. eHealthMe is studying from 121,894 B12 users. Check the latest studies of B12.
What is Twynsta?
Twynsta has active ingredients of amlodipine besylate; telmisartan. It is often used in high blood pressure. eHealthMe is studying from 1,063 Twynsta users. Check the latest studies of Twynsta.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
29 people who take B12 and Twynsta together, and have interactions are studied.

What are the common drug interactions of B12 and Twynsta, by gender? *:
female:
- Nasopharyngitis (inflammation of the nasopharynx)
- Oropharyngeal pain
- Pain
- Wheezing (a high-pitched whistling sound made while you breath)
- Malaise (a feeling of general discomfort or uneasiness)
- Asthma
- Dyspnoea (difficult or laboured respiration)
- Pyrexia (fever)
- Respiratory tract infection
- Weight decreased
male:
- Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
- Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
- Infusion site extravasation (flow of (blood or lymph) from infusion site)
- Neurological symptom (symptoms of nervous system disease)
- Flushing (the warm, red condition of human skin)
- Abdominal pain
- Arrhythmia (irregular heartbeat)
- Asthenia (weakness)
- Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
- Blood potassium decreased
What are the common drug interactions of B12 and Twynsta, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Nasopharyngitis (inflammation of the nasopharynx)
- Oropharyngeal pain
- Pain
- Wheezing (a high-pitched whistling sound made while you breath)
- Malaise (a feeling of general discomfort or uneasiness)
- Asthma
- Dyspnoea (difficult or laboured respiration)
- Pyrexia (fever)
- Respiratory tract infection
- Weight decreased
50-59:
- Abdominal pain
- Arrhythmia (irregular heartbeat)
- Asthenia (weakness)
- Blood potassium decreased
- Localised intraabdominal fluid collection (collection of fluid in abdomen in single site)
- Nausea (feeling of having an urge to vomit)
- Pain
- Spleen disorder (disease of spleen)
- Chest pain
- Dyspnoea (difficult or laboured respiration)
60+:
- Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
- Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
- Infusion site extravasation (flow of (blood or lymph) from infusion site)
- Neurological symptom (symptoms of nervous system disease)
- Flushing (the warm, red condition of human skin)
- Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
- Contusion (a type of hematoma of tissue in which capillaries)
- Small intestinal obstruction (blockage in small intestine)
- Cerebral haemorrhage (bleeding within the brain)
- Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
What are the existing conditions these people have? *
- Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 19 people, 65.52%
- Asthma: 4 people, 13.79%
- Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 2 people, 6.90%
- Thrombosis (formation of a blood clot inside a blood vessel): 2 people, 6.90%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 6.90%
* Approximation only. Some reports may have incomplete information.
Do you take B12 and Twynsta?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of B12 and Twynsta:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of B12:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Twynsta:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between B12 and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Twynsta and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on cobalamin and amlodipine besylate; telmisartan (the active ingredients of B12 and Twynsta, respectively), and B12 and Twynsta (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Ferrous Fumarate cause Otitis Externa? - 17 seconds ago
- Could Nexium cause Enterococcal Infection? - 20 seconds ago
- Could Aredia cause Ventricular Fibrillation? - 24 seconds ago
- Could Sertraline cause Central Nervous System Lesion? - 27 seconds ago
- Could Arava cause Acne Cystic? - 29 seconds ago
- Could Aranesp cause Viral Infection? - 36 seconds ago
- Could Tretinoin cause Application Site Swelling? - 36 seconds ago
- Could Norco cause Diabetes? - 52 seconds ago
- Could Trilipix cause Neck Pain? - 53 seconds ago
- Could Fluoxetine Hydrochloride cause Unilateral Hydronephrosis? - 54 seconds ago